Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation
Launched by BOSTON CHILDREN'S HOSPITAL · Mar 17, 2015
Trial Information
Current as of April 29, 2025
Withdrawn
Keywords
ClinConnect Summary
Bronchoscopy-guided tissue sampling is a central technique in many diseases including diagnosing and staging lung cancers, diagnosing interstitial lung diseases, and acute and/or chronic rejections following lung transplantation. Confocal fluorescence microscopy is a novel technique used for in vivo microscopic imaging of proximal and distal airways including bronchial and alveolar walls, microvessels, and inflammatory cells. We hypothesize that confocal fluorescence microscopy images of bronchiolar and alveolar structures during standard bronchoscopy could help recognize and classify the p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • to be older than six years of age
- • to be undergoing surveillance or clinically indicated bronchoscopies with transbronchial biopsy as part of their routine care
- • to be willing and able to comply with study procedures and provide written informed consent/assent to participate in the study
- Exclusion Criteria:
- • to be unwilling to consent
- • to be unable to safely tolerate a bronchoscopic procedure
- • to have any contraindications to short-acting anesthetic agents
- • to have any contraindications to transbronchial biopsies
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Gary Visner, DO
Study Director
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials